TD Cowen Issues Pessimistic Forecast for P3 Health Partners (NASDAQ:PIII) Stock Price

P3 Health Partners (NASDAQ:PIII) had its price target reduced by equities researchers at TD Cowen from $0.90 to $0.25 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen’s price objective would indicate a potential upside of 13.84% from the company’s current price.

P3 Health Partners Trading Up 7.8 %

Shares of PIII stock opened at $0.22 on Wednesday. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 1.11. The company has a market cap of $78.56 million, a PE ratio of -0.26 and a beta of 1.15. The business’s 50 day moving average is $0.37 and its two-hundred day moving average is $0.50. P3 Health Partners has a 12 month low of $0.19 and a 12 month high of $1.78.

Insider Buying and Selling

In related news, major shareholder Pacific Founders Ugp I. Chicago acquired 80,000 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was bought at an average price of $0.49 per share, for a total transaction of $39,200.00. Following the acquisition, the insider now directly owns 76,785,438 shares of the company’s stock, valued at approximately $37,624,864.62. The trade was a 0.10 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders purchased a total of 400,000 shares of company stock valued at $205,600 over the last three months. Company insiders own 17.86% of the company’s stock.

Hedge Funds Weigh In On P3 Health Partners

Hedge funds have recently added to or reduced their stakes in the stock. Sanders Morris Harris LLC lifted its position in shares of P3 Health Partners by 16.3% in the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock worth $64,000 after purchasing an additional 20,000 shares during the period. Renaissance Technologies LLC boosted its position in P3 Health Partners by 188.1% during the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock worth $50,000 after purchasing an additional 73,000 shares during the period. Emfo LLC grew its position in shares of P3 Health Partners by 39.8% in the second quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after purchasing an additional 406,418 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock valued at $398,000 after acquiring an additional 550,925 shares during the period. Finally, Armistice Capital LLC purchased a new stake in shares of P3 Health Partners in the second quarter worth $3,557,000. Institutional investors own 7.75% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.